Modulating hydrogel crosslink density and degradation to control bone morphogenetic protein delivery and in vivo bone formation

Julianne Holloway, Henry Ma, Reena Rai, Jason A. Burdick

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Bone morphogenetic proteins (BMPs) show promise in therapies for improving bone formation after injury; however, the high supraphysiological concentrations required for desired osteoinductive effects, off-target concerns, costs, and patient variability have limited the use of BMP-based therapeutics. To better understand the role of biomaterial design in BMP delivery, a matrix metalloprotease (MMP)-sensitive hyaluronic acid (HA)-based hydrogel was used for BMP-2 delivery to evaluate the influence of hydrogel degradation rate on bone repair in vivo. Specifically, maleimide-modified HA (MaHA) macromers were crosslinked with difunctional MMP-sensitive peptides to permit protease-mediated hydrogel degradation and growth factor release. The compressive, rheological, and degradation properties ofMaHA hydrogelswere characterized as a function of crosslink density, which was varied through either MaHA concentration (1-5 wt.%) or maleimide functionalization (10-40%f). Generally, the compressive moduli increased, the time to gelation decreased, and the degradation rate decreased with increasing crosslink density. Furthermore, BMP-2 release increased with either a decrease in the initial crosslink density or an increase in collagenase concentration (non-specific MMP degradation). Lastly, two hydrogel formulationswith distinct BMP-2 release profileswere evaluated in a critical-sized calvarial defect model in rats. After six weeks, minimal evidence of bone repair was observedwithin defects left empty or filled with hydrogels alone. For hydrogels that contained BMP-2, similar volumes of new bone tissue were formed; however, the faster degrading hydrogel exhibited improved cellular invasion, bone volume to total volume ratio, and overall defect filling. These results illustrate the importance of coordinating hydrogel degradation with the rate of new tissue formation.

Original languageEnglish (US)
Pages (from-to)63-70
Number of pages8
JournalJournal of Controlled Release
Volume191
DOIs
StatePublished - Oct 10 2014
Externally publishedYes

Fingerprint

Bone Morphogenetic Proteins
Hydrogel
Osteogenesis
Bone Morphogenetic Protein 2
Metalloproteases
Bone and Bones
Hydrogels
Hyaluronic Acid
Biocompatible Materials
Collagenases
Intercellular Signaling Peptides and Proteins
Peptide Hydrolases
Costs and Cost Analysis
Peptides
Wounds and Injuries
Therapeutics
maleimide

Keywords

  • Bone morphogenetic protein
  • Bone repair
  • Calvarial defect
  • Hyaluronic acid
  • Hydrogel

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Modulating hydrogel crosslink density and degradation to control bone morphogenetic protein delivery and in vivo bone formation. / Holloway, Julianne; Ma, Henry; Rai, Reena; Burdick, Jason A.

In: Journal of Controlled Release, Vol. 191, 10.10.2014, p. 63-70.

Research output: Contribution to journalArticle

@article{1ac3ee2f8298473f8de2a2d4a26fb2f4,
title = "Modulating hydrogel crosslink density and degradation to control bone morphogenetic protein delivery and in vivo bone formation",
abstract = "Bone morphogenetic proteins (BMPs) show promise in therapies for improving bone formation after injury; however, the high supraphysiological concentrations required for desired osteoinductive effects, off-target concerns, costs, and patient variability have limited the use of BMP-based therapeutics. To better understand the role of biomaterial design in BMP delivery, a matrix metalloprotease (MMP)-sensitive hyaluronic acid (HA)-based hydrogel was used for BMP-2 delivery to evaluate the influence of hydrogel degradation rate on bone repair in vivo. Specifically, maleimide-modified HA (MaHA) macromers were crosslinked with difunctional MMP-sensitive peptides to permit protease-mediated hydrogel degradation and growth factor release. The compressive, rheological, and degradation properties ofMaHA hydrogelswere characterized as a function of crosslink density, which was varied through either MaHA concentration (1-5 wt.{\%}) or maleimide functionalization (10-40{\%}f). Generally, the compressive moduli increased, the time to gelation decreased, and the degradation rate decreased with increasing crosslink density. Furthermore, BMP-2 release increased with either a decrease in the initial crosslink density or an increase in collagenase concentration (non-specific MMP degradation). Lastly, two hydrogel formulationswith distinct BMP-2 release profileswere evaluated in a critical-sized calvarial defect model in rats. After six weeks, minimal evidence of bone repair was observedwithin defects left empty or filled with hydrogels alone. For hydrogels that contained BMP-2, similar volumes of new bone tissue were formed; however, the faster degrading hydrogel exhibited improved cellular invasion, bone volume to total volume ratio, and overall defect filling. These results illustrate the importance of coordinating hydrogel degradation with the rate of new tissue formation.",
keywords = "Bone morphogenetic protein, Bone repair, Calvarial defect, Hyaluronic acid, Hydrogel",
author = "Julianne Holloway and Henry Ma and Reena Rai and Burdick, {Jason A.}",
year = "2014",
month = "10",
day = "10",
doi = "10.1016/j.jconrel.2014.05.053",
language = "English (US)",
volume = "191",
pages = "63--70",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",

}

TY - JOUR

T1 - Modulating hydrogel crosslink density and degradation to control bone morphogenetic protein delivery and in vivo bone formation

AU - Holloway, Julianne

AU - Ma, Henry

AU - Rai, Reena

AU - Burdick, Jason A.

PY - 2014/10/10

Y1 - 2014/10/10

N2 - Bone morphogenetic proteins (BMPs) show promise in therapies for improving bone formation after injury; however, the high supraphysiological concentrations required for desired osteoinductive effects, off-target concerns, costs, and patient variability have limited the use of BMP-based therapeutics. To better understand the role of biomaterial design in BMP delivery, a matrix metalloprotease (MMP)-sensitive hyaluronic acid (HA)-based hydrogel was used for BMP-2 delivery to evaluate the influence of hydrogel degradation rate on bone repair in vivo. Specifically, maleimide-modified HA (MaHA) macromers were crosslinked with difunctional MMP-sensitive peptides to permit protease-mediated hydrogel degradation and growth factor release. The compressive, rheological, and degradation properties ofMaHA hydrogelswere characterized as a function of crosslink density, which was varied through either MaHA concentration (1-5 wt.%) or maleimide functionalization (10-40%f). Generally, the compressive moduli increased, the time to gelation decreased, and the degradation rate decreased with increasing crosslink density. Furthermore, BMP-2 release increased with either a decrease in the initial crosslink density or an increase in collagenase concentration (non-specific MMP degradation). Lastly, two hydrogel formulationswith distinct BMP-2 release profileswere evaluated in a critical-sized calvarial defect model in rats. After six weeks, minimal evidence of bone repair was observedwithin defects left empty or filled with hydrogels alone. For hydrogels that contained BMP-2, similar volumes of new bone tissue were formed; however, the faster degrading hydrogel exhibited improved cellular invasion, bone volume to total volume ratio, and overall defect filling. These results illustrate the importance of coordinating hydrogel degradation with the rate of new tissue formation.

AB - Bone morphogenetic proteins (BMPs) show promise in therapies for improving bone formation after injury; however, the high supraphysiological concentrations required for desired osteoinductive effects, off-target concerns, costs, and patient variability have limited the use of BMP-based therapeutics. To better understand the role of biomaterial design in BMP delivery, a matrix metalloprotease (MMP)-sensitive hyaluronic acid (HA)-based hydrogel was used for BMP-2 delivery to evaluate the influence of hydrogel degradation rate on bone repair in vivo. Specifically, maleimide-modified HA (MaHA) macromers were crosslinked with difunctional MMP-sensitive peptides to permit protease-mediated hydrogel degradation and growth factor release. The compressive, rheological, and degradation properties ofMaHA hydrogelswere characterized as a function of crosslink density, which was varied through either MaHA concentration (1-5 wt.%) or maleimide functionalization (10-40%f). Generally, the compressive moduli increased, the time to gelation decreased, and the degradation rate decreased with increasing crosslink density. Furthermore, BMP-2 release increased with either a decrease in the initial crosslink density or an increase in collagenase concentration (non-specific MMP degradation). Lastly, two hydrogel formulationswith distinct BMP-2 release profileswere evaluated in a critical-sized calvarial defect model in rats. After six weeks, minimal evidence of bone repair was observedwithin defects left empty or filled with hydrogels alone. For hydrogels that contained BMP-2, similar volumes of new bone tissue were formed; however, the faster degrading hydrogel exhibited improved cellular invasion, bone volume to total volume ratio, and overall defect filling. These results illustrate the importance of coordinating hydrogel degradation with the rate of new tissue formation.

KW - Bone morphogenetic protein

KW - Bone repair

KW - Calvarial defect

KW - Hyaluronic acid

KW - Hydrogel

UR - http://www.scopus.com/inward/record.url?scp=84906946132&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906946132&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2014.05.053

DO - 10.1016/j.jconrel.2014.05.053

M3 - Article

VL - 191

SP - 63

EP - 70

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

ER -